XML 38 R26.htm IDEA: XBRL DOCUMENT
v3.22.4

Fair Value Measurements and Fair Values of Financial Instruments | 12 Months Ended
--- | ---
Dec. 31, 2022
Fair Value Measurements and Fair Values of Financial Instruments [Abstract] |
Fair Value Measurements and Fair Values of Financial Instruments | Note 18 - Fair Value Measurements and Fair Values of Financial Instruments Management uses its best judgment in estimating the fair value of the Company’s financial instruments; however, there are inherent weaknesses in any estimation technique. Therefore, for substantially all financial instruments, the fair value estimates herein are not necessarily indicative of the amounts the Company could have realized in a sales transaction on the dates indicated. The estimated fair value amounts have been measured as of their respective year-ends and have not been re-evaluated or updated for purposes of these consolidated financial statements subsequent to those respective dates. As such, the estimated fair values of these financial instruments subsequent to the respective reporting dates may be different than the amounts reported at each year-end. ASC Topic 820, Fair Value Measurements and Disclosures, establishes a fair value hierarchy that prioritizes the inputs to valuation methods used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). An asset’s or liability’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. For assets and liabilities measured at fair value on a recurring basis, the fair value measurements, by level, within the fair value hierarchy are as follows:
|  |  |  |  | (Level 1) |  | (Level 2) |  |  |
|  |  |  |  | Quoted Prices in |  | Significant |  | (Level 3)
|  |  |  |  | Active Markets |  | Other |  | Significant
|  |  |  |  | for Identical |  | Observable |  | Unobservable
Description |  | Total |  | Assets |  | Inputs |  | Inputs
|  | (In Thousands)
As of December 31, 2022: |  |  |  |  |  |  |  |  |  |  |  |
Securities Available for Sale |  |  |  |  |  |  |  |  |  |  |  |
Debt Securities Available for Sale |  | $ | 91,715 |  | $ | - |  | $ | 91,715 |  | $ | -
Marketable Equities |  |  | 17,686 |  |  | 17,686 |  |  | - |  |  | -
Total Securities Available for Sale |  | $ | 109,401 |  | $ | 17,686 |  | $ | 91,715 |  | $ | -
As of December 31, 2021: |  |  |  |  |  |  |  |  |  |  |  |
Securities Available for Sale |  |  |  |  |  |  |  |  |  |  |  |
Debt Securities Available for Sale |  | $ | 85,186 |  | $ | - |  | $ | 85,186 |  | $ | -
Marketable Equities |  |  | 25,187 |  |  | 25,187 |  |  | - |  |  | -
Total Securities Available for Sale |  | $ | 110,373 |  | $ | 25,187 |  | $ | 85,186 |  | $ | -
For assets and liabilities measured at fair value on a nonrecurring basis, the fair value measurements by level within the fair value hierarchy are as follows:
|  |  |  |  | (Level 1) |  | (Level 2) |  |  |
|  |  |  |  | Quoted Prices in |  | Significant |  | (Level 3)
|  |  |  |  | Active Markets |  | Other |  | Significant
|  |  |  |  | for Identical |  | Observable |  | Unobservable
Description |  | Total |  | Assets |  | Inputs |  | Inputs
|  | (In Thousands)
As of December 31, 2022: |  |  |  |  |  |  |  |  |  |  |  |
Impaired loans |  | $ | 5,587 |  | $ | - |  | $ | - |  | $ | 5,587
Other real estate owned |  | $ | 75 |  | $ | - |  | $ | - |  | $ | 75
As of December 31, 2021: |  |  |  |  |  |  |  |  |  |  |  |
Impaired loans |  | $ | 14,796 |  | $ | - |  | $ | - |  | $ | 14,796
Other real estate owned |  | $ | 75 |  | $ | - |  | $ | - |  | $ | 75
Certain impaired loans were adjusted to the fair value, less costs to sell, of the underlying collateral securing these loans resulting in losses. The loss is not recorded directly as an adjustment to current earnings, but rather as a component in determining the allowance for loan losses. Fair value was measured using appraised values of collateral and adjusted as necessary by management based on unobservable inputs for specific properties. Losses (recoveries) on impaired loans for the years ended December 31, 2022 and 2021 were ($5.0) million and $5.7 million respectively. The following table presents additional quantitative information about assets measured at fair value on a nonrecurring basis and for which the Company has utilized adjusted Level 3 inputs to determine fair value, (Dollars in thousands):
Quantitative Information about Level 3 Fair Value Measurements
|  | Fair Value | Valuation | Unobservable | Range
|  | Estimate | Techniques | Input |
December 31, 2022: |  |  |  |  |
Impaired Loans | $ | 5,587 | Appraisal of collateral (1) | Appraisal adjustments (2) | 0%-10%
Other Real Estate Owned | $ | 75 | Appraisal of collateral (1) | Appraisal adjustments (2) | 0%-10%
Note 18- Fair Value Measurements and Fair Value of Financial Instruments (continued)
Quantitative Information about Level 3 Fair Value Measurements
|  | Fair Value | Valuation | Unobservable | Range
|  | Estimate | Techniques | Input |
December 31, 2021: |  |  |  |  |
Impaired Loans | $ | 14,796 | Appraisal of collateral (1) | Appraisal adjustments (2) | 0%-10%
Other Real Estate Owned | $ | 75 | Appraisal of collateral (1) | Appraisal adjustments (2) | 0%-10%
(1)Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various level 3 inputs which are not identifiable. (2)Appraisals may be adjusted by management for qualitative factors such as age of appraisal, expected condition of property, economic conditions, and estimated liquidation expenses. The range of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal. The following information should not be interpreted as an estimate of the fair value of the entire Company since a fair value calculation is only provided for a limited portion of the Company’s assets and liabilities. Due to a wide range of valuation techniques and the degree of subjectivity used in making the estimates, comparisons between the Company’s disclosures and those of other companies may not be meaningful. The following methods and assumptions were used to estimate the fair values of the Company’s financial instruments at December 31, 2022 and 2021: Cash and Cash Equivalents (Carried at Cost) The carrying amounts reported in the consolidated statements of financial condition for cash and interest-earning deposits approximate those assets’ fair values. Securities (Carried at Fair Value) The fair value of securities is determined by obtaining quoted market prices on nationally recognized securities exchanges (Level 1), or matrix pricing (Level 2), which is a mathematical technique used widely in the industry to value debt securities without relying exclusively on quoted market prices for the specific securities but rather by relying on the securities’ relationship to other benchmark quoted prices. Loans Held for Sale (Carried at Cost) The fair value of loans held for sale is determined, when possible, using quoted secondary-market prices. If no such quoted prices exist, the fair value of a loan is determined using quoted prices for a similar loan or loans, adjusted for specific attributes of that loan. Loans held for sale are carried at the lower of cost or fair value. Loans Receivable (Carried at Cost) The fair values of loans, except for certain impaired loans, are estimated using discounted cash flow analyses, using market rates at the date of the Statement of Financial Condition that reflect the credit and interest rate-risk inherent in the loans. Projected future cash flows are calculated based upon contractual maturity or call dates, projected repayments and prepayments of principal. Generally, for variable rate loans that reprice frequently and with no significant change in credit risk, fair values are based on carrying values. Impaired Loans (Generally Carried at Fair Value) Impaired loans are those for which the Company has measured and recorded an impairment generally based on the fair value of the loan’s collateral, less estimated costs to sell. Fair value is generally determined based upon independent third-party appraisals of the properties, or discounted cash flows based upon the expected proceeds. These assets are included as Level 3 fair values, based upon the lowest level of input that is significant to the fair value measurements. The fair value at December 31, 2022 and 2021 consists of the loan balances of $8,371,000 and $22,624,000 net of a valuation allowance of $2,784,000 and $7,828,000, respectively. FHLB of New York Stock (Carried at Cost) The carrying amount of restricted investment in bank stock approximates fair value, and considers the limited marketability of such securities. Accrued Interest Receivable and Payable (Carried at Cost) The carrying amount of accrued interest receivable and accrued interest payable approximates its fair value. Deposits (Carried at Cost) The fair values disclosed for demand deposits (e.g., interest and non-interest checking, passbook savings and money market accounts) are, by definition, equal to the amount payable on demand at the reporting date (i.e., their carrying amounts). Fair values for fixed-rate certificates of deposit are estimated using a discounted cash flow calculation that applies interest rates currently being offered in the market on certificates to a schedule of aggregated expected monthly maturities on time deposits. Debt Including Subordinated Debentures (Carried at Cost) Fair values of debt are estimated using discounted cash flow analysis, based on quoted prices for new long-term debt with similar credit risk characteristics, terms and remaining maturity. These prices obtained from this active market represent a market value that is deemed to represent the transfer price if the liability were assumed by a third party. Note 18- Fair Value Measurements and Fair Value of Financial Instruments (continued) Off-Balance Sheet Financial Instruments (Disclosed at Cost) Fair values for the Bank’s off-balance sheet financial instruments (lending commitments and unused lines of credit) are based on fees currently charged in the market to enter into similar agreements, taking into account, the remaining terms of the agreements and the counterparties’ credit standing. The fair value of these commitments was deemed immaterial and is not presented in the accompanying table. The carrying values and estimated fair values of financial instruments were as follows at December 31, 2022 and 2021:
|  |  | As of December 31, 2022
|  |  |  |  |  |  |  | Quoted Prices in Active |  | Significant |  | Significant
|  | Carrying |  |  |  |  | Markets for Identical Assets |  | Other Observable Inputs |  | Unobservable Inputs
|  | Value |  | Fair Value |  | (Level 1) |  | (Level 2) |  | (Level 3)
|  | (In Thousands)
Financial assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 229,359 |  | $ | 229,359 |  | $ | 229,359 |  | $ | - |  | $ | -
Interest-earning time deposits |  |  | 735 |  |  | 735 |  |  | - |  |  | 735 |  |  | -
Debt securities available for sale |  |  | 91,715 |  |  | 91,715 |  |  | - |  |  | 91,715 |  |  | -
Equity investments |  |  | 17,686 |  |  | 17,686 |  |  | 17,686 |  |  | - |  |  | -
Loans held for sale |  |  | 658 |  |  | 658 |  |  | - |  |  | 658 |  |  | -
Loans receivable, net |  |  | 3,045,331 |  |  | 2,876,925 |  |  | - |  |  | - |  |  | 2,876,925
FHLB of New York stock, at cost |  |  | 20,113 |  |  | 20,113 |  |  | - |  |  | 20,113 |  |  | -
Accrued interest receivable |  |  | 13,455 |  |  | 13,455 |  |  | - |  |  | 13,455 |  |  | -
Financial liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deposits |  |  | 2,811,607 |  |  | 2,499,978 |  |  | 1,713,754 |  |  | 786,224 |  |  | -
Debt |  |  | 382,261 |  |  | 377,227 |  |  | - |  |  | 377,227 |  |  | -
Subordinated debentures |  |  | 37,508 |  |  | 40,113 |  |  | - |  |  | 40,113 |  |  | -
Accrued interest payable |  |  | 3,073 |  |  | 3,073 |  |  | - |  |  | 3,073 |  |  | -
|  |  | As of December 31, 2021
|  |  |  |  |  |  |  | Quoted Prices in Active |  | Significant |  | Significant
|  | Carrying |  |  |  |  | Markets for Identical Assets |  | Other Observable Inputs |  | Unobservable Inputs
|  | Value |  | Fair Value |  | (Level 1) |  | (Level 2) |  | (Level 3)
|  | (In Thousands)
Financial assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 411,629 |  | $ | 411,629 |  | $ | 411,629 |  | $ | - |  | $ | -
Interest-earning time deposits |  |  | 735 |  |  | 735 |  |  | - |  |  | 735 |  |  | -
Debt securities available for sale |  |  | 85,186 |  |  | 85,186 |  |  | - |  |  | 85,186 |  |  | -
Equity investments |  |  | 25,187 |  |  | 25,187 |  |  | 25,187 |  |  | - |  |  | -
Loans held for sale |  |  | 952 |  |  | 952 |  |  | - |  |  | 952 |  |  | -
Loans receivable, net |  |  | 2,304,942 |  |  | 2,313,204 |  |  | - |  |  | - |  |  | 2,313,204
FHLB of New York stock, at cost |  |  | 6,084 |  |  | 6,084 |  |  | - |  |  | 6,084 |  |  | -
Accrued interest receivable |  |  | 9,183 |  |  | 9,183 |  |  | - |  |  | 9,183 |  |  | -
Financial liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deposits |  |  | 2,561,402 |  |  | 2,520,191 |  |  | 1,881,121 |  |  | 639,070 |  |  | -
Debt |  |  | 71,711 |  |  | 71,214 |  |  | - |  |  | 71,214 |  |  | -
Subordinated debentures |  |  | 37,275 |  |  | 45,020 |  |  | - |  |  | 45,020 |  |  | -
Accrued interest payable |  |  | 1,051 |  |  | 1,051 |  |  | - |  |  | 1,051 |  |  | -
+

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration